Skip to Main Content

Paper Details

Fatty acid metabolism underlies venetoclax resistance in acute myeloid leukemia stem cells.
Nat Cancer
129
2020
AML, AML cells, AML stem cells, FAO, Fatty acid, RAS, Venetoclax, acute myeloid leukemia, acute myeloid leukemia stem cells, amino acid, aza, azacitidine, drug, drug resistant AML cells, fatty acid, patients, primitive AML cells, ven, venetoclax
Author NameAffiliation
Brett M StevensUniversity of Colorado Denver
Courtney L JonesUniversity of Colorado Denver
Daniel A PollyeaUniversity of Colorado Denver
Rachel Culp-HillUniversity of Colorado Denver
Angelo D'AlessandroUniversity of Colorado Denver
Angelo D'AlessandroUniversity of Colorado Denver
Angelo D'AlessandroUniversity of Colorado Denver
Angelo D'AlessandroUniversity of Colorado Denver
Amanda WintersUniversity of Colorado Denver
Anna KrugUniversity of Colorado Denver
Diana AbbottUniversity of Colorado Denver
Shanshan PeiUniversity of Colorado Denver
Haobin YeUniversity of Colorado Denver
Michael W BeckerJames P. Wilmot Cancer Center
Clayton A SmithUniversity of Colorado Denver
Veronica Clavijo JordanUniversity of Colorado Denver
Veronica Clavijo JordanUniversity of Colorado Denver
  • 1 - 17

Datasets

Release 1.2